Assessment of Performance of Manufacturing Procedures in a Unit for Production of Investigational Anticancer Agents, Using a Mixed Effects Analysis

por van der Schoot, S. C., Nuijen, B., Huitema, A. D. R., Beijnen, J. H.
Publicado 2007

A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer

por Veltkamp, S A, Thijssen, B, Garrigue, J S, Lambert, G, Lallemand, F, Binlich, F, Huitema, A D R, Nuijen, B, Nol, A, Beijnen, J H, Schellens, J H M
Publicado 2006

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

por Rohaan, M.W., Gomez-Eerland, R., van den Berg, J.H., Geukes Foppen, M.H., van Zon, M., Raud, B., Jedema, I., Scheij, S., de Boer, R., Bakker, N.A.M., van den Broek, D., Pronk, L.M., Grijpink-Ongering, L.G., Sari, A., Kessels, R., van den Haak, M., Mallo, H.A., Karger, M., van de Wiel, B.A., Zuur, C.L., Duinkerken, C.W., Lalezari, F., van Thienen, J.V., Wilgenhof, S., Blank, C.U., Beijnen, J.H., Nuijen, B., Schumacher, T.N., Haanen, J.B.A.G.
Publicado 2022